AIM: To examine changes in levels of gingival crevicular fluid (GCF) cytokines, after periodontal therapy of generalized aggressive periodontitis (GAgP). MATERIALS AND METHODS:Twenty-five periodontally healthy and 24 GAgP subjects had periodontal clinical parameters measured and gingival crevicular fluid (GCF) samples collected from up to 14 sites/subject. GCF samples were analysed using multiplex bead immunoassay for: GM-CSF, IFN-γ, IL-10, IL-1β, IL-2, IL-6 and TNF-α. Aggressive periodontitis subjects were randomly assigned to either scaling and root planing (SRP) alone or SRP plus systemic amoxicillin (500 mg) and metronidazole (400 mg) 3 times a day for 14 days. Clinical parameters and GCF cytokines were re-measured 6 months after treatment. Differences over time were analysed using the Wilcoxon test and between groups using the Mann-Whitney test. RESULTS: Significant reductions in GCF GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in GCF IL-6 were detected after therapy. The mean change in GCF cytokines did not differ significantly between groups. CONCLUSIONS:Periodontal therapy improved GCF cytokine profiles by lowering IL-1β and increasing IL-10 levels. The reduction in GCF GM-CSF after therapy implicates this cytokine in the pathogenesis of GAgP. There was no difference between therapies in changes of GCF cytokines.
RCT Entities:
AIM: To examine changes in levels of gingival crevicular fluid (GCF) cytokines, after periodontal therapy of generalized aggressive periodontitis (GAgP). MATERIALS AND METHODS: Twenty-five periodontally healthy and 24 GAgP subjects had periodontal clinical parameters measured and gingival crevicular fluid (GCF) samples collected from up to 14 sites/subject. GCF samples were analysed using multiplex bead immunoassay for: GM-CSF, IFN-γ, IL-10, IL-1β, IL-2, IL-6 and TNF-α. Aggressive periodontitis subjects were randomly assigned to either scaling and root planing (SRP) alone or SRP plus systemic amoxicillin (500 mg) and metronidazole (400 mg) 3 times a day for 14 days. Clinical parameters and GCF cytokines were re-measured 6 months after treatment. Differences over time were analysed using the Wilcoxon test and between groups using the Mann-Whitney test. RESULTS: Significant reductions in GCF GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in GCF IL-6 were detected after therapy. The mean change in GCF cytokines did not differ significantly between groups. CONCLUSIONS: Periodontal therapy improved GCF cytokine profiles by lowering IL-1β and increasing IL-10 levels. The reduction in GCF GM-CSF after therapy implicates this cytokine in the pathogenesis of GAgP. There was no difference between therapies in changes of GCF cytokines.
Authors: P Stashenko; P Fujiyoshi; M S Obernesser; L Prostak; A D Haffajee; S S Socransky Journal: J Clin Periodontol Date: 1991-08 Impact factor: 8.728
Authors: Federica Romano; Loretta Bongiovanni; Laura Bianco; Federica Di Scipio; Zhiqian Yang; Andrea Elio Sprio; Giovanni Nicolao Berta; Mario Aimetti Journal: Clin Oral Investig Date: 2017-09-16 Impact factor: 3.573
Authors: Dennis Beliveau; Ingvar Magnusson; John A Bidwell; Edward F Zapert; Ikramuddin Aukhil; Shannon M Wallet; Luciana M Shaddox Journal: J Clin Periodontol Date: 2012-08-29 Impact factor: 8.728
Authors: Janet S Kinney; Thiago Morelli; Min Oh; Thomas M Braun; Christoph A Ramseier; Jim V Sugai; William V Giannobile Journal: J Clin Periodontol Date: 2013-12-12 Impact factor: 8.728
Authors: Jeffrey L Ebersole; Radhakrishnan Nagarajan; David Akers; Craig S Miller Journal: Front Cell Infect Microbiol Date: 2015-08-19 Impact factor: 5.293